Following its acquisition of Silk Road in September, Boston Scientific said it plans to consolidate the company’s work in Minnesota.
Boston Scientific to close Silk Road Medical headquarters, lay off 138 people Read More »
Artificial intelligence tools could help solve workforce challenges. Implementation, however, can be difficult, pushing organizations to consider less risky administrative and back-office tasks first.
AI could be a game changer, but healthcare needs to be ‘exceedingly careful’ Read More »
A clinical research associate is a professional who oversees clinical trials. Here are our top tips on how to become one.
What You Need to Know to Become a Clinical Research Associate Read More »
The Trusted Exchange Framework and Common Agreement went live in December with five Qualified Health Information Networks. Two more were added early this year.
Oracle Health to apply for QHIN status under TEFCA data sharing framework Read More »
CEO Roy Jakobs expects the slump to continue into 2025, driven by China’s anti-corruption measures.
Philips cuts sales forecast after ‘significant deterioration’ in China Read More »
Hologic has recalled the Biozorb devices after 188 reports of adverse events in patients who received the implants in breast tissue.
FDA advises clinicians to stop using Hologic radiographic markers Read More »
Healthcare organizations will need to test models in their local environments, keep an eye on performance and work together to implement the technology, panelists said at HLTH.
Thoughtful implementation, ongoing monitoring key to safe health AI Read More »
The acquisition of Aliada Therapeutics gives AbbVie access to a Phase I anti-amyloid antibody as well as the biotech’s novel platform engineered for efficient blood-brain barrier transport.
AbbVie Doubles Down on Alzheimer’s With $1.4B Aliada Buy Read More »
The Swiss pharma is paying $150 million upfront to gain rights to Monte Rosa’s VAV1-targeting molecular glue degraders, led by a Phase I candidate which holds therapeutic promise for immune-mediated diseases.
Novartis Inks Potential $2.2B Molecular Glue Deal With Monte Rosa Read More »
Laboratories face a series of upcoming deadlines to comply with stricter FDA oversight of in-house tests. Here are five strategies labs can take to be ready.
5 steps to navigate the FDA’s new lab developed test rule Read More »
